Single Dose Study to Evaluate Dose-proportionality of Vortioxetine Hemihydrobromide Orally Disintegrating Tablets
Clinical trial NCT05416762 · COMPLETED
Trial details
- NCT number
- NCT05416762
- Sponsor
- Seasons Biotechnology (Taizhou) Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-19
- Primary completion
- 2022-11-25
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.